ロード中...
Bevacizumab for the management of diabetic macular edema
Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age population and is relatedto 1%-5% of cases of blindness worldwide. Diabetic macular edema (DME) is the most frequent cause of DR vision loss and is an important public health problem. Recent studies have implicated vascul...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627413/ https://ncbi.nlm.nih.gov/pubmed/23593532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i2.19 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|